Effect of Two Food Supplements on Lipid Profile in Patients With Mild Hypercholesterolemia
Recruiting
N/A
Interventional Study
Hypercholesterolemia
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 35 – 70
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 40 (estimated)
- Sponsor
- Fondazione IRCCS Policlinico San Matteo di Pavia · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The primary outcome is to evaluate the effect of Cynacol on the change in LDL-C levels compared to Metacol after 90 days of supplementation.
The secondary outcomes are to evaluate:
\- the change of TC, non-HDL cholesterol (non-HDL-C), apolipoprotein B (apoB), Tg, HDL-C levels after 90 days of supplementation with Cynacol compared to Metacol. The safety outcome is collection of the adverse events…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* age between 35-70 years
* both genders
* LDL-C levels between 115 and 190 mg/dl
* subjects able to understand the informed consent and sign it before enrollment in the study
Exclusion Criteria:
* personal history of cardiovascular disease or equivalent risk factors
* Tg leve…
Contacts
No contact information available.